Stuttgart - Delayed Quote EUR
Planet 13 Holdings Inc (Y7Q.SG)
0.2060
-0.0040
(-1.90%)
At close: May 16 at 9:33:50 PM GMT+2
Loading Chart for Y7Q.SG
- Previous Close
0.2100 - Open
0.2240 - Bid 0.2100 x --
- Ask 0.2540 x --
- Day's Range
0.2060 - 0.2240 - 52 Week Range
0.1480 - 0.6000 - Volume
0 - Avg. Volume
222 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Aug 4, 2025 - Aug 19, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: Y7Q.SG
View MorePerformance Overview: Y7Q.SG
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
Y7Q.SG
34.81%
S&P/TSX Composite index (^GSPTSE)
5.49%
1-Year Return
Y7Q.SG
62.20%
S&P/TSX Composite index (^GSPTSE)
16.47%
3-Year Return
Y7Q.SG
69.71%
S&P/TSX Composite index (^GSPTSE)
28.53%
5-Year Return
Y7Q.SG
69.71%
S&P/TSX Composite index (^GSPTSE)
77.42%
Compare To: Y7Q.SG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
0.2060
-1.90%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
1.1840
+8.42%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.5750
+5.29%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.4100
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
1.2720
+1.44%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.35
-7.76%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.5850
-4.88%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.6000
-4.76%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.3750
-1.57%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.0960
+5.19%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.4950
+3.45%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
Statistics: Y7Q.SG
View MoreValuation Measures
As of 5/16/2025
Market Cap
72.90M
Enterprise Value
102.89M
Trailing P/E
--
Forward P/E
20.70
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.58
Price/Book (mrq)
0.67
Enterprise Value/Revenue
0.99
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--